PE56794A1 - Sulfonilaminopirimidina - Google Patents

Sulfonilaminopirimidina

Info

Publication number: PE56794A1
Authority: PE; Peru
Prior art keywords: alkyl; hydrogen; alcoxyl; nr10r11; hetero
Prior art date: 1993-06-28

Application number

PE1994245279A

Other languages

English (en)

Spanish (es)

Inventor

Martine Clozel

Volker Breu

Kaspar Burri

Jean-Marie Cassal

Henri Ramuz

Georges Hirth

Bernd-Michael Loffler

Marcel Muller

Werner Neidhart

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-28

Filing date

1994-06-27

Publication date

1995-02-07

1994-06-27 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1995-02-07 Publication of PE56794A1 publication Critical patent/PE56794A1/es

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Pyridine Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PE1994245279A 1993-06-28 1994-06-27 Sulfonilaminopirimidina PE56794A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH192493		1993-06-28

Publications (1)

Publication Number	Publication Date
PE56794A1 true PE56794A1 (es)	1995-02-07

Family

ID=4221780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PE1994245279A PE56794A1 (es)	1993-06-28	1994-06-27	Sulfonilaminopirimidina

Country Status (41)

Country	Link
US (1)	US5541186A (de)
EP (1)	EP0633259B1 (de)
JP (1)	JP2545200B2 (de)
KR (1)	KR100338905B1 (de)
CN (1)	CN1050839C (de)
AT (1)	ATE175669T1 (de)
AU (1)	AU678467B2 (de)
BG (1)	BG61691B1 (de)
BR (2)	BR9402558A (de)
CA (1)	CA2125730C (de)
CO (1)	CO4230230A1 (de)
CZ (1)	CZ287184B6 (de)
DE (1)	DE59407626D1 (de)
DK (1)	DK0633259T3 (de)
EC (1)	ECSP941111A (de)
ES (1)	ES2127850T3 (de)
FI (1)	FI112944B (de)
GR (1)	GR3029874T3 (de)
HR (1)	HRP940370B1 (de)
HU (2)	HUT67636A (de)
IL (1)	IL110089A (de)
IS (1)	IS4185A (de)
LT (1)	LT3723B (de)
LV (1)	LV11175B (de)
MY (1)	MY110871A (de)
NO (1)	NO306403B1 (de)
NZ (1)	NZ260842A (de)
PE (1)	PE56794A1 (de)
PH (1)	PH30688A (de)
PL (2)	PL177031B1 (de)
RO (1)	RO114325B1 (de)
RU (1)	RU2142457C1 (de)
SG (1)	SG43888A1 (de)
SI (1)	SI0633259T1 (de)
SK (1)	SK280736B6 (de)
SV (1)	SV1994000028A (de)
TW (1)	TW394761B (de)
UA (1)	UA40578C2 (de)
UY (1)	UY23797A1 (de)
YU (1)	YU40794A (de)
ZA (1)	ZA944434B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5514696A (en) *	1992-05-06	1996-05-07	Bristol-Myers Squibb Co.	Phenyl sulfonamide endothelin antagonists
US6743783B1 (en) *	1993-12-01	2004-06-01	Marine Polymer Technologies, Inc.	Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6063911A (en) *	1993-12-01	2000-05-16	Marine Polymer Technologies, Inc.	Methods and compositions for treatment of cell proliferative disorders
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
EP0790826A4 (de)	1994-11-16	1998-11-11	Synaptic Pharma Corp	Dyhydropyrimidine und deren verwendungen
US6268369B1 (en)	1994-11-16	2001-07-31	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
CA2162630C (en) *	1994-11-25	2007-05-01	Volker Breu	Sulfonamides
RU2151767C1 (ru) *	1994-12-20	2000-06-27	Ф.Хоффманн-Ля Рош Аг	Сульфонамиды и фармацевтическая композиция
TW313568B (de) *	1994-12-20	1997-08-21	Hoffmann La Roche
PT801062E (pt) *	1994-12-28	2003-08-29	Kowa Co	Derivados de pirimidina
US5760038A (en) *	1995-02-06	1998-06-02	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) *	1995-02-06	1998-07-14	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
US5573762A (en) *	1995-04-24	1996-11-12	Genentech, Inc.	Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
US5739333A (en) *	1995-05-16	1998-04-14	Tanabe Seiyaku Co., Ltd.	Sulfonamide derivative and process for preparing the same
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
EP0852226B1 (de) *	1995-09-06	2003-11-19	Kowa Co. Ltd.	Pyrimidinderivate
JPH09124620A (ja)	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
CZ260596A3 (en) *	1995-10-12	1997-12-17	Hoffmann La Roche	Sulfonamide derivative, process of its preparation and pharmaceutical composition containing thereof
US6228861B1 (en)	1995-11-16	2001-05-08	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
WO1997022595A1 (en) *	1995-12-20	1997-06-26	Yamanouchi Pharmaceutical Co., Ltd.	Arylethenesulfonamide derivatives and drug composition containing the same
EP0904077A4 (de)	1996-02-20	1999-12-22	Bristol Myers Squibb Co	Verfahren zur herstellung von biphenyl-isoxazole-sulfonamiden
US5856507A (en) *	1997-01-21	1999-01-05	Bristol-Myers Squibb Co.	Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) *	1996-04-09	1999-08-17	Bristol-Myers Squibb Co.	Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US6172066B1 (en)	1996-05-16	2001-01-09	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6245773B1 (en)	1996-05-16	2001-06-12	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
CA2265972A1 (en) *	1996-09-16	1998-03-26	Philip D. Acott	Use of igf-i for the treatment of polycystic kidney disease and related indications
TW536540B (en) *	1997-01-30	2003-06-11	Bristol Myers Squibb Co	Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
WO1998033781A1 (en) *	1997-01-30	1998-08-06	Bristol-Myers Squibb Company	Method for preventing or treating low renin hypertension by administering an endothelin antagonist
US6680323B2 (en)	1998-12-23	2004-01-20	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6274585B1 (en)	1998-12-23	2001-08-14	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US7566452B1 (en)	1999-05-04	2009-07-28	New York University	Cancer treatment with endothelin receptor antagonists
CA2315614C (en) *	1999-07-29	2004-11-02	Pfizer Inc.	Pyrazoles
AU2001265871A1 (en) *	2000-04-25	2001-11-07	Actelion Pharmaceuticals Ltd	Substituted sulfonylaminopyrimidines
US6720324B2 (en)	2000-07-05	2004-04-13	Synaptic Pharmaceutical Corporation	Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
MY140724A (en)	2000-07-21	2010-01-15	Actelion Pharmaceuticals Ltd	Novel arylethene-sulfonamides
US6670362B2 (en)	2000-09-20	2003-12-30	Pfizer Inc.	Pyridazine endothelin antagonists
JP2004509874A (ja)	2000-09-25	2004-04-02	アクテリオン　ファマシューティカルズ　リミテッド	新規なアリールアルカン−スルフォンアミド類
CN1935793B (zh) *	2000-10-17	2010-06-23	庵原化学工业株式会社	取代的苯胺化合物的制备方法
US6639082B2 (en)	2000-10-17	2003-10-28	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
KR100374326B1 (ko) *	2000-11-29	2003-03-03	한국과학기술연구원	6-히드록시-1, 3-디옥신-4-온 고리를 가진인간면역결핍바이러스 프로테아제 억제 화합물 및 그의제조방법
HU229403B1 (en)	2000-12-18	2013-12-30	Actelion Pharmaceuticals Ltd	Novel sulfamides and their use as endothelin receptor antagonists
WO2002083650A1 (en) *	2001-04-11	2002-10-24	Actelion Pharmaceuticals Ltd	Novel sulfonylamino-pyrimidines
AU2011218661B2 (en) *	2002-05-24	2012-07-05	Millennium Pharmaceuticals, Inc.	CCR9 inhibitors and methods of use thereof
EP2399903A1 (de) *	2002-05-24	2011-12-28	Millennium Pharmaceuticals, Inc.	CCR9-Hemmer und Verwendungsverfahren dafür
US7741519B2 (en)	2007-04-23	2010-06-22	Chemocentryx, Inc.	Bis-aryl sulfonamides
US7420055B2 (en) *	2002-11-18	2008-09-02	Chemocentryx, Inc.	Aryl sulfonamides
US7227035B2 (en) *	2002-11-18	2007-06-05	Chemocentryx	Bis-aryl sulfonamides
US6939885B2 (en) *	2002-11-18	2005-09-06	Chemocentryx	Aryl sulfonamides
JP4769460B2 (ja) *	2002-12-02	2011-09-07	アクテリオンファーマシューティカルズリミテッド	新規スルファミド類
DE102004027119A1 (de)	2003-06-06	2004-12-30	Schott Ag	UV-Strahlung absorbierendes Glas mit geringer Absorption im sichtbaren Bereich, ein Verfahren zu seiner Herstellung sowie dessen Verwendung
CN1930135B (zh) *	2004-03-05	2011-12-28	弗·哈夫曼-拉罗切有限公司	作为p2x3和p2x2/3拮抗剂的二氨基嘧啶
JP4926943B2 (ja) *	2004-04-13	2012-05-09	シンタファーマシューティカルズコーポレーション	Ｉｌ−１２産生を阻害する二塩
DK1763517T3 (da) *	2004-06-28	2011-06-06	Hoffmann La Roche	Pyrimidinderivater som 11beta-HSD1-inhibitorer
KR100847203B1 (ko) *	2004-06-28	2008-07-17	에프. 호프만-라 로슈 아게	피리미딘 유도체
TW200628467A (en)	2004-11-11	2006-08-16	Actelion Pharmaceuticals Ltd	Novel sulfamides
CA2620129C (en)	2005-09-01	2014-12-23	F. Hoffmann-La Roche Ag	Diaminopyrimidines as p2x3 and p2x2/3 modulators
WO2007025900A1 (en) *	2005-09-01	2007-03-08	F. Hoffmann-La Roche Ag	Diaminopyrimidines as p2x3 and p3x2/3 modulators
CA2619919C (en) *	2005-09-01	2014-04-01	F. Hoffmann-La Roche Ag	Diaminopyrimidines as p2x3 and p2x2/3 modulators
MX2008011842A (es) *	2006-03-13	2008-10-02	Encysive Pharmaceuticals Inc	Procedimientos y composiciones para el tratamiento de insuficiencia cardiaca diastolica.
MX2008011844A (es) *	2006-03-13	2008-10-02	Encysive Pharmaceuticals Inc	Formulaciones de sitaxsentano de sodio.
US20080026061A1 (en) *	2006-06-22	2008-01-31	Reichwein John F	Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
AR062501A1 (es)	2006-08-29	2008-11-12	Actelion Pharmaceuticals Ltd	Composiciones terapeuticas
US8871247B2 (en)	2007-02-19	2014-10-28	Marine Polymer Technologies, Inc.	Hemostatic compositions and therapeutic regimens
MX2010001837A (es)	2007-08-17	2010-03-10	Actelion Pharmaceuticals Ltd	Derivados de 4-pirimidinasulfamida.
WO2011130646A1 (en)	2010-04-15	2011-10-20	Marine Polymer Technologies, Inc.	Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
NZ732118A (en)	2011-04-15	2018-11-30	Marine Polymer Tech Inc	Treatment of disease with poly-n-acetylglucosamine nanofibers
RU2604060C1 (ru) *	2015-10-06	2016-12-10	федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России)	Способ получения 2,5-дизамещенных 6-гидроксипиримидин-4(3н)-онов
AR107928A1 (es)	2016-03-22	2018-06-28	Merck Sharp & Dohme	Moduladores alostéricos de receptores de acetilcolina nicotínicos
RU2643356C2 (ru) *	2016-06-22	2018-02-01	федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации	Новое n-арилсульфамидное производное о-бензоиламинобензойной кислоты, обладающее анксиолитической, актопротекторной и антидепрессивной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0210526B1 (de)	1985-07-24	1989-05-24	Siemens Aktiengesellschaft	Kernreaktorbrennelement
TW270116B (de) *	1991-04-25	1996-02-11	Hoffmann La Roche
RU2086544C1 (ru)	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW287160B (de) *	1992-12-10	1996-10-01	Hoffmann La Roche

1994
- 1994-06-08 TW TW083105221A patent/TW394761B/zh not_active IP Right Cessation
- 1994-06-13 CA CA002125730A patent/CA2125730C/en not_active Expired - Fee Related
- 1994-06-16 ES ES94109257T patent/ES2127850T3/es not_active Expired - Lifetime
- 1994-06-16 SG SG1996004116A patent/SG43888A1/en unknown
- 1994-06-16 EP EP94109257A patent/EP0633259B1/de not_active Expired - Lifetime
- 1994-06-16 DK DK94109257T patent/DK0633259T3/da active
- 1994-06-16 AT AT94109257T patent/ATE175669T1/de active
- 1994-06-16 DE DE59407626T patent/DE59407626D1/de not_active Expired - Lifetime
- 1994-06-16 SI SI9430236T patent/SI0633259T1/xx unknown
- 1994-06-21 ZA ZA944434A patent/ZA944434B/xx unknown
- 1994-06-22 IL IL11008994A patent/IL110089A/xx not_active IP Right Cessation
- 1994-06-24 IS IS4185A patent/IS4185A/is unknown
- 1994-06-24 AU AU65948/94A patent/AU678467B2/en not_active Ceased
- 1994-06-24 NZ NZ260842A patent/NZ260842A/en unknown
- 1994-06-24 HR HR01924/93-6A patent/HRP940370B1/xx not_active IP Right Cessation
- 1994-06-24 HU HU9401907A patent/HUT67636A/hu unknown
- 1994-06-27 PL PL94323036A patent/PL177031B1/pl unknown
- 1994-06-27 PL PL94304007A patent/PL175771B1/pl unknown
- 1994-06-27 CO CO94027814A patent/CO4230230A1/es unknown
- 1994-06-27 LV LVP-94-131A patent/LV11175B/lv unknown
- 1994-06-27 LT LTIP1979A patent/LT3723B/lt not_active IP Right Cessation
- 1994-06-27 MY MYPI94001661A patent/MY110871A/en unknown
- 1994-06-27 NO NO942428A patent/NO306403B1/no unknown
- 1994-06-27 FI FI943084A patent/FI112944B/fi not_active IP Right Cessation
- 1994-06-27 EC EC1994001111A patent/ECSP941111A/es unknown
- 1994-06-27 US US08/266,072 patent/US5541186A/en not_active Expired - Lifetime
- 1994-06-27 PE PE1994245279A patent/PE56794A1/es not_active Application Discontinuation
- 1994-06-27 CZ CZ19941573A patent/CZ287184B6/cs not_active IP Right Cessation
- 1994-06-27 BR BR9402558A patent/BR9402558A/pt not_active Application Discontinuation
- 1994-06-27 RU RU94022258/04A patent/RU2142457C1/ru not_active IP Right Cessation
- 1994-06-27 BG BG98880A patent/BG61691B1/bg unknown
- 1994-06-27 PH PH48525A patent/PH30688A/en unknown
- 1994-06-27 YU YU40794A patent/YU40794A/sh unknown
- 1994-06-27 CN CN94106574A patent/CN1050839C/zh not_active Expired - Fee Related
- 1994-06-27 UA UA94005281A patent/UA40578C2/uk unknown
- 1994-06-27 UY UY23797A patent/UY23797A1/es not_active IP Right Cessation
- 1994-06-27 KR KR1019940014774A patent/KR100338905B1/ko not_active Expired - Fee Related
- 1994-06-28 SV SV1994B00028A patent/SV1994000028A/es not_active Application Discontinuation
- 1994-06-28 RO RO94-01112A patent/RO114325B1/ro unknown
- 1994-06-28 JP JP6146003A patent/JP2545200B2/ja not_active Expired - Fee Related
- 1994-06-28 SK SK779-94A patent/SK280736B6/sk unknown
1995
- 1995-06-21 HU HU95P/P00298P patent/HU211533A9/hu unknown
1996
- 1996-12-05 BR BR1100089-9A patent/BR1100089A/pt active IP Right Grant
1999
- 1999-04-05 GR GR990400963T patent/GR3029874T3/el unknown

Also Published As

Publication number	Publication date
EP0633259A1 (de)	1995-01-11
UA40578C2 (uk)	2001-08-15
DK0633259T3 (da)	1999-09-06
AU678467B2 (en)	1997-05-29
CN1050839C (zh)	2000-03-29
CZ157394A3 (en)	1995-01-18
HUT67636A (en)	1995-04-28
RU94022258A (ru)	1996-04-20
CZ287184B6 (en)	2000-10-11
DE59407626D1 (de)	1999-02-25
HU211533A9 (en)	1995-12-28
FI943084A7 (fi)	1994-12-29
KR100338905B1 (ko)	2002-11-13
LTIP1979A (en)	1995-01-31
CN1106007A (zh)	1995-08-02
IS4185A (is)	1994-12-29
ECSP941111A (es)	1994-11-16
YU40794A (sh)	1997-07-31
BG98880A (bg)	1995-05-31
ZA944434B (en)	1995-01-03
PL304007A1 (en)	1995-01-09
IL110089A (en)	2000-08-31
FI943084A0 (fi)	1994-06-27
ATE175669T1 (de)	1999-01-15
UY23797A1 (es)	1994-12-16
CA2125730C (en)	2005-10-18
LV11175B (en)	1996-06-20
SG43888A1 (en)	1997-11-14
NO306403B1 (no)	1999-11-01
KR950000676A (ko)	1995-01-03
HU9401907D0 (en)	1994-09-28
IL110089A0 (en)	1994-10-07
PL177031B1 (pl)	1999-09-30
LV11175A (lv)	1996-04-20
JP2545200B2 (ja)	1996-10-16
GR3029874T3 (en)	1999-07-30
HRP940370B1 (en)	1999-12-31
FI112944B (fi)	2004-02-13
US5541186A (en)	1996-07-30
CO4230230A1 (es)	1995-10-19
NO942428D0 (no)	1994-06-27
SK77994A3 (en)	1995-03-08
PL175771B1 (pl)	1999-02-26
RU2142457C1 (ru)	1999-12-10
BG61691B1 (bg)	1998-03-31
CA2125730A1 (en)	1994-12-29
BR9402558A (pt)	1995-03-28
SV1994000028A (es)	1995-04-19
JPH0717972A (ja)	1995-01-20
LT3723B (en)	1996-02-26
BR1100089A (pt)	2000-03-14
EP0633259B1 (de)	1999-01-13
RO114325B1 (ro)	1999-03-30
MY110871A (en)	1999-05-31
PH30688A (en)	1997-09-16
AU6594894A (en)	1995-01-05
HRP940370A2 (en)	1996-12-31
NO942428L (no)	1994-12-29
ES2127850T3 (es)	1999-05-01
TW394761B (en)	2000-06-21
SK280736B6 (sk)	2000-07-11
NZ260842A (en)	1996-05-28
SI0633259T1 (en)	1999-06-30

Legal Events

Date	Code	Title	Description
1996-03-29	FG	Grant, registration
2005-02-28	FD	Application declared void or lapsed

Publication	Publication Date	Title
PE56794A1 (es)	1995-02-07	Sulfonilaminopirimidina
CY1105899T1 (el)	2011-02-02	Πυριδινοϋλοπιπepιδινες ως 5-ht1f αγωνιστες
NO20051577L (no)	2005-05-27	Azaaren-derivater
PE20030809A1 (es)	2003-09-22	Derivados de piperidina como antagonistas de la hormona concentradora de la melanina (mch)
ES8105694A1 (es)	1981-06-16	Procedimiento para la produccion de propenilaminas
AR017236A1 (es)	2001-08-22	Compuestos biciclo [2.2.1] heptanos, composiciones farmaceuticas, procedimientos para tratar
CO5271680A1 (es)	2003-04-30	Compuestos
DK0799206T3 (da)	2003-01-27	Aryl- og heteroaryl-sulfonamidderivater, fremstillingen deraf og anvendelsen deraf som endothelinantagonister
ATE182595T1 (de)	1999-08-15	Dihalogenierte ferrocene und verfahren zu deren herstellung
KR870005995A (ko)	1987-07-08	피리(미)딜-옥시-및-티오-벤조산 유도체의 제조 방법
PE133799A1 (es)	2000-01-10	Antagonistas del receptor de trombina
PT1064281E (pt)	2005-10-31	Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
FR2699918B1 (fr)	1995-03-17	Ligands sélectifs des récepteurs 5HY1D-5HT1B dérivés d'indole-pipérazine utiles comme médicaments.
DE69208604D1 (de)	1996-04-04	Imidazol-Verbindungen, ihre Herstellung und Verwendung als Calcium-Kanal Blocker
DK1021405T3 (da)	2003-02-03	Azetidinonderivater til behandling af HCMV-infektioner
ATE390432T1 (de)	2008-04-15	Phosphinverbindung, zwischenverbindung, palladiumkomplex, und deren verwendung
ATE93517T1 (de)	1993-09-15	Mercapto-phenylalkanoylaminosaeure-amide, deren herstellung und deren verwendung als collagenase- inhibitoren.
ATE57930T1 (de)	1990-11-15	Dihydropyridine.
ES2176036T3 (es)	2002-11-16	Sintesis quimica de derivados de morfolina.
PE20020413A1 (es)	2002-05-18	Derivados de 1-aminobutano-3-ol como agonistas de la gabapentina
RU2005104419A (ru)	2005-11-20	Способ получения нитрооксипроизводных напроксена
PE52496A1 (es)	1996-12-12	Nueva sulfonamida y procedimiento de obtencion
MX9800081A (es)	1998-11-29	Bencilhidroxilaminas y productos intermedios para su preparacion.
DE60011226D1 (de)	2004-07-08	Substituierte 1-(piperidin-4-yl)-3-(aryl)-isothioharnstoffe , ihre herstellung und therapeutische verwendung
ES421767A2 (es)	1977-07-01	Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2.